Sage Journals: Discover world-class research

Free access

Research article

First published 2015-1

Evaluation of Algorithms for the Treatment of Problem Bleeding Episodes in Patients With Hemophilia Having Inhibitors

Guy Young, Jerome Teitel, Roseline d’Oiron [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2020-6

Slightly elevated international normalized ratio predicts bleeding episodes in patients treated with direct oral anticoagulants

Priya Bhardwaj, Louise Breum Petersen, Tomas Sorm Binko [...]

Journal of International Medical Research

Retricted access

Research article

First published 2009-03

Hospitalized Women Experiencing an Episode of Excessive Oral Anticoagulation Had a Higher Bleeding Risk Than Men

Monica Cosma Rochat, Gérard Waeber, Jean-Blaise Wasserfallen [...]

Journal of Women's Health

Open access

Review article

First published 2025

Evaluating the Safety and Efficacy of Concizumab in Hemophilia A/B Patients: A Systematic Review

Erum Siddiqui, Maliha Khalid, Muhammad Saad Khan [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2026

Twelve-month follow-up of a real-world,noninterventional study evaluating the impact of emicizumab on bleeding episodes,joint health,and quality of life in people with hemophilia A

Anupam Dutta, Taniya Sarkar Dutta, Luish Borboruah [...]

Therapeutic Advances in Hematology

Free access

Research article

First published 2013-10

Vascular Hamartoma in the Uterus of a Female Sprague-Dawley Rat with an Episode of Vaginal Bleeding

Mariko Shirota, Jun Kawashima, Tomohiro Nakamura [...]

Toxicologic Pathology

Free access

Review article

First published 2014-10

BAX326 (RIXUBIS): a novel recombinant factor IX for the control and prevention of bleeding episodes in adults and children with hemophilia B

Jerzy Windyga, Maria Helena Solano Trujillo, Andrea E. Hafeman

Therapeutic Advances in Hematology

Free access

Review article

First published 2018-10

The role of emicizumab,a bispecific factor IXa- and factor X-directed antibody,for the prevention of bleeding episodes in patients with hemophilia A

Tristan Knight, Michael U. Callaghan

Therapeutic Advances in Hematology

Retricted access

Research article

First published 1975-10

Incidence of Bleeding Complications in Patients on Intermittent IV Heparin Therapy

Robert J. Ignoffo

Annals of Pharmacotherapy

Retricted access

Other

First published 2011-8

Classification of Posttonsillectomy Hemorrhage

Stephanie Sarny, Guenther Ossimitz, Walter Habermann [...]

Otolaryngology–Head and Neck Surgery

Search results